SILO Pharma Profit Margin

The latest profit margin for SILO is -8269.53% as of June 2026. That compares with -6789.22% in the prior-year period — down 21.8% year over year. That is below the Finance sector average of 31.21%. Investors often review this figure alongside SILO Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, SILO's profit margin moved from -6789.22% to -8269.53% — a 21.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in SILO Pharma's valuation or profitability profile.

Against Finance companies, SILO currently prints -8269.53% for profit margin, while the sector average sits near 31.21%. That is roughly 26592.4% below the sector mean. Large gaps often invite a closer look at SILO Pharma's growth, margins, and balance sheet.

Profit Margin shows how effectively SILO Pharma converts resources into returns. At -8269.53%, SILO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -6789.22% in the prior-year period — down 21.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SILO's profit margin (-8269.53%), review year-over-year change from -6789.22%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.